Franklin Resources Inc Angion Biomedica Corp. Transaction History

Franklin Resources Inc

  • $334 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$2.35 - $9.95 $1.45 Million - $6.12 Million
-615,255 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$9.31 - $13.25 $2,374 - $3,378
255 Added 0.04%
615,255 $6.01 Million
Q1 2021

May 13, 2021
BUY
$15.01 - $25.74 $9.23 Million - $15.8 Million
615,000 New
615,000 $11.1 Million

About Angion Biomedica Corp.

ANGN Quotes by TradingView
  • Ticker ANGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,113,300
  • Description
  • Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...
More about ANGN
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email